Technology Solution Clause Samples

POPULAR SAMPLE Copied 2 times
Technology Solution. Attachment 8-A shall include a description of the Equipment, Materials and Systems used in the delivery of the Services, including representations as to the purpose, features and functionality of such Equipment, Materials and Systems. Service Provider is required to implement the Equipment, Materials and Systems as set forth in Attachment 8-A. Service Provider may propose a change to such Equipment, Materials and Systems set forth in Attachment 8-A, provided that the replaced or substituted Equipment, Materials and Systems satisfies the initial representations as to the purpose, features and functionality of such Equipment, Materials and Systems and which change will be subject to DIR review and approval.
View SourceView Similar (5)
Technology Solution. Attachment 8-A shall include a description of the Equipment, Materials, and Systems used in the delivery of the Services, including representations as to the purpose, features, and functionality of such Equipment, Materials, and Systems. Service Provider is required to implement the Equipment, Materials, and Systems as set forth in Attachment 8-A. Service Provider may propose a change to such Equipment, Materials, and Systems set forth in Attachment 8-A, provided that the replaced or substituted Equipment, Materials, and Systems satisfies the initial representations as to the purpose, features, and functionality of such Equipment, Materials, and Systems and which change will be subject to DIR review and approval.
View SourceView Similar (3)
Technology Solution. Provided Client complies with the terms and conditions of this Agreement, Client may be given access to a technology solution(s), provided by ▇▇▇ or a third party, to facilitate or in connection with the performance of this Agreement, such as ▇▇▇’s proprietary web-based portal known as “Aya Connect” (collectively, the “Technology Solutions”). Client agrees to comply with all terms of use requirements for such Technology Solutions, and to execute further agreements as may be required to obtain access to such systems. The current terms of use of Aya Connect can be found at: ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇/entity-terms-of-use-22-01 (the “Terms of Use”) and accessed by password: “TOU2022!”, and are incorporated by reference herein as though set forth in full at this point. Client agrees to the Terms of Use and that it is an “Entity” as defined and used in the Terms of Use.
View Source
Technology Solution. Exhibit 8 shall include a description of the Equipment, Materials and Systems used in the delivery of the Services, including representations as to the purpose, features and functionality of such Equipment, Materials and Systems. Service Provider is required to implement the Equipment, Materials and Systems as set forth in Exhibit 8. Service Provider may propose a change to such Equipment, Materials and Systems set forth in Exhibit 8, provided that the replaced or substituted Equipment, Materials and Systems satisfies the initial representations as to the purpose, features and functionality of such Equipment, Materials and Systems and which change shall be subject to TxDOT review and approval.
View Source
Technology Solution 
View Source

Related to Technology Solution

  • Technology Discoveries, innovations, Know-How and inventions, whether patentable or not, including computer software, recognized under U.S. law as intellectual creations to which rights of ownership accrue, including, but not limited to, patents, trade secrets, maskworks and copyrights developed under this Agreement.

  • Technology Access Contractor expressly acknowledges that state funds may not be expended in connection with the purchase of an automated information system unless that system meets certain statutory requirements relating to accessibility by persons with visual impairments. Accordingly, Contractor represents and warrants to System Agency that the technology provided to System Agency for purchase (if applicable under this Contract or any related Solicitation) is capable, either by virtue of features included within the technology or because it is readily adaptable by use with other technology, of: • providing equivalent access for effective use by both visual and non-visual means; • presenting information, including prompts used for interactive communications, in formats intended for non-visual use; and • being integrated into networks for obtaining, retrieving, and disseminating information used by individuals who are not blind or visually impaired. For purposes of this Section, the phrase “equivalent access” means a substantially similar ability to communicate with or make use of the technology, either directly by features incorporated within the technology or by other reasonable means such as assistive devices or services which would constitute reasonable accommodations under the Americans With Disabilities Act or similar state or federal laws. Examples of methods by which equivalent access may be provided include, but are not limited to, keyboard alternatives to mouse commands and other means of navigating graphical displays, and customizable display appearance. In accordance with Section 2157.005 of the Texas Government Code, the Technology Access Clause contract provision remains in effect for any contract entered into before September 1, 2006.

  • Technology Upgrades Notwithstanding any other provision of this Agreement, Verizon shall have the right to deploy, upgrade, migrate and maintain its network at its discretion. The Parties acknowledge that Verizon, at its election, may deploy fiber throughout its network and that such fiber deployment may inhibit or facilitate Covista’s ability to provide service using certain technologies. Nothing in this Agreement shall limit Verizon's ability to modify its network through the incorporation of new equipment or software or otherwise. Covista shall be solely responsible for the cost and activities associated with accommodating such changes in its own network.

  • Telemedicine Services This plan covers clinically appropriate telemedicine services when the service is provided via remote access through an on-line service or other interactive audio and video telecommunications system in accordance with R.I. General Law § 27-81-1. Clinically appropriate telemedicine services may be obtained from a network provider, and from our designated telemedicine service provider. When you seek telemedicine services from our designated telemedicine service provider, the amount you pay is listed in the Summary of Medical Benefits. When you receive a covered healthcare service from a network provider via remote access, the amount you pay depends on the covered healthcare service you receive, as indicated in the Summary of Medical Benefits. For information about telemedicine services, our designated telemedicine service provider, and how to access telemedicine services, please visit our website or contact our Customer Service Department.

  • Manufacturing Technology Transfer Except as provided in Section 4.3(f)(iii)(1) and Section 6.10, with respect to any Collaboration Product (or LGC Reserved Product, if applicable) for which LGC (or its Affiliate) performed CMC Development or CMC Manufacturing, if (a) Cue does not elect for LGC to perform CMC Step 2, CMC Step 3, or CMC Step 4 (or with respect to LGC Reserved Products, upon completion of CMC Step 1), or (b) upon failure of the Parties to reach agreement with respect to a Clinical Supply Agreement or a Commercial Supply Agreement or (c) [***] under this Agreement and does not cure such breach within [***] days (provided, that if such breach is not reasonably capable of cure within such [***] day period, then such cure period shall be automatically extended for an additional [***] day period as long as LGC continues to use diligent efforts to cure such breach in accordance with a reasonable cure plan and if such breach is not reasonably capable of cure within such combined [***] day period, then Cue shall reasonably consider consenting to any extension of such cure period as long as LGC continues to use diligent efforts to cure such breach in accordance with a reasonable cure plan), as applicable, then, in each case upon the written request of Cue, LGC shall use Commercially Reasonable Efforts to make a technology transfer to an Approved CMO the Manufacturing processes (including materials and such other information) but solely as is necessary to enable the Manufacture of such Collaboration Product (including the Collaboration Compound therein) (or LGC Reserved Product, including the LGC Reserved Compound therein, if applicable) by such Approved CMO to comparable biochemical structure, quality and purity as that Manufactured by LGC or its Affiliate or CMO, provided that neither Cue, LGC or any Third Party shall perform such a technology transfer to any CMO [***] without LGC’s consent, not to be unreasonably withheld, conditioned or delayed if LGC has approved the CMO to manufacture Collaboration Products (or LGC Reserved Products, if applicable). LGC shall conduct such technology transfer as soon as reasonably practicable after receiving such written notice, using good faith efforts to support supply needed to achieve timelines in the Cue Territory Development Plan (or Cue’s development plan for LGC Reserved Products, if applicable) or Cue Territory Commercialization Plan, as applicable. LGC shall conduct the first technology transfer for each Collaboration Product (or LGC Reserved Products, if applicable) [***] (provided that [***]) for a period of up to [***] months from the date Cue or its designee has provided notice it is ready to receive the technology transfer, provided, that such [***] month period [***]. After the expiration of the initial such [***] month period for a Collaboration Product (or LGC Reserved Products, if applicable), if required to complete the technology transfer to enable the Manufacture of such Collaboration Product (including the Collaboration Compound therein) (or LGC Reserved Product, including the LGC Reserved Compound therein, if applicable) by such Approved CMO to comparable biochemical structure, quality and purity as that Manufactured by LGC, LGC shall continue to provide support to Cue for up to an additional [***] period for up to [***] hours at the FTE Rate and thereafter at [***]. Thereafter, LGC will also provide [***] for such Collaboration Product (or LGC Reserved Products, if applicable). Neither Cue nor its Affiliates or Cue Collaborators shall reverse engineer any materials provided hereunder by LGC. Notwithstanding anything in this Agreement to the contrary, LGC’s CMC information may only be shared with an Approved CMO.